Under the expanded contract, Elsevier will also offer its customers a path to license the ExitCare software solution, which is the gateway to achieving Meaningful Use.
ExitCare’s content already provides Elsevier customers with access to an expansive library of patient education information available in multiple languages, including the recent addition of ExitCare’s patient education content within Elsevier’s Clinical Pharmacology.
ExitCare president Roger Jacobi said the company’s content and technology products complement each other to address customers’ needs such as Meaningful Use, care transitions, improving workflow and patient empowerment.